OncoGaze™ makes precision therapy relevant for more patients.
By delivering critical genomic insights at the biopsy stage, Acurion’s OncoGaze™ empowers oncologists to make precision therapy a reality for more patients.
OncoGaze™ workflow predicts clinically-actionable genomic biomarkers from routine digital histological tissue slides.
OncoGaze™ uncovers hidden morphological patterns invisible to the human eye – accelerating biomarker screening.
OncoGaze™ provides actionable genomic test results within seconds, rather than months, unlocking life-saving precision therapies when time matters most.
This technology was developed by leading oncologists and some of the most highly cited cancer researchers in the world.